This week on the Health Data Ethics Podcast, I sat down with Doug Meil to talk about his new book, "The Rise and Fall of Explorys and IBM Watson Health." What started as a discussion about a decade-long journey in health tech turned into a reflection on ambition, acquisition, and the hard-earned lessons of analytics. Doug talked about missed opportunities, broke down the reasons why they were missed, and gave great advice for what future innovators can take away from Explorys's story. If you’re working in healthcare data at all, it’s essential listening. One key theme that stuck with me: Iterate relentlessly, but don’t ignore the fundamentals—especially data access. Also loved his advice for the next generation of health tech leaders: Build for impact, not just headlines. Check out our conversation if you’re thinking about where health AI is headed, or just want a better understanding of how big bets like IBM Watson Health can shape the industry.